Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-20-001532

Options or other derivatives

  • President and CEO acquired 391,177 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Torley Helen · President and CEO

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-02-10 Grant or award : show line 1 in the form Option to Purchase Common Stock +266,051 $19.98 2030-02-10 266,051 266,051 D
2020-02-10 Grant or award : show line 2 in the form Restricted Stock Units +125,126 $0.00 125,126 125,126 D
Loading xslF345X03/edgar.xml…